[Comparative drug therapy study with scintigraphic control research]

Area of Science:

• Rheumatology
• Nuclear Medicine
• Pharmacology

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting joints.
• Synovial blood circulation changes are key indicators of RA inflammation.
• Assessing antirheumatic drug efficacy requires accurate inflammation measurement.

Purpose of the Study:

• To evaluate the therapeutic effects of antirheumatic drugs in rheumatoid arthritis patients.
• To document changes in synovial blood circulation as a measure of inflammation.
• To identify potential sources of error in quantitative scintigraphic assessments.

Main Methods:

• Utilized 99m-Tc-pertechnetate joint scintigraphy for imaging.
• Quantitatively assessed changes in synovial blood circulation.
• Compared inflammation in affected joints to a standardized reference region on the forearm.

Main Results:

• Scintigraphy demonstrated changes in synovial blood circulation in response to antirheumatic drugs.
• Increased activity in the reference region on the forearm was observed.
• This increase in the reference region posed a potential source of error in quantitative analysis.

Conclusions:

• Synovial blood circulation changes measured by 99m-Tc-pertechnetate scintigraphy can reflect antirheumatic drug effects in RA.
• Early vascular involvement in RA can lead to inaccuracies in quantitative assessments using standard reference regions.
• Development of joint- and radio-nuclide-specific standards is crucial for reliable quantitative analysis in RA scintigraphy.